Cas no 290815-26-8 (Avosentan)
Avosentan structure
Product Name:Avosentan
CAS No:290815-26-8
MF:C23H21N5O5S
MW:479.508343458176
MDL:MFCD23843806
CID:258784
PubChem ID:9912992
Update Time:2025-04-19
Avosentan Chemical and Physical Properties
Names and Identifiers
-
- N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
- Avosentan
- 2-Pyridinesulfonamide,N-[6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methy...
- 2-Pyridinesulfonamide,N-[6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl-
- N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)-pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
- 2-Pyridinesulfonamide, N-(6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl)-5-methyl-
- 5-methylpyridine-2-sulfonic acid (6-methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)pyrimidin-4-yl)amide
- 5-methylpyridine-2-sulfonic acid [6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]amide
- Ro 67-0565
- SPP301
- SPP-301
- UNII-L94KSX715K
- N-[6-Methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl-2-pyridinesulfonamide
- 290815-26-8
- Q27074636
- F84811
- BCP28417
- RO-67-0565
- Ro670565
- L001646
- MS-28915
- Avosentan,CAS:290815-26-8
- SCHEMBL2742679
- AC-33590
- NCGC00379058-01
- YBWLTKFZAOSWSM-UHFFFAOYSA-N
- L94KSX715K
- Avosentan [INN]
- DTXSID30183330
- 2-Pyridinesulfonamide, N-[6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl-
- CS-0625
- Ro 67-0565; SPP-301
- N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide
- 5-methyl-pyridine-2-sulfonic acid [6-methoxy-5-(2-methoxy-phenoxy)-2-pyridin-4-yl-pyrimidin-4-yl]-amide
- FT-0662342
- CHEMBL3989834
- HY-15195
- SPP 301
- HMS3741G07
- GTPL8260
- 5-methyl-pyridine-2-sulfonic acid[6-methoxy-5-(2-methoxy-phenoxy)-2-pyridin-4-yl-pyrimidin-4-yl]-amide
- BDBM50532577
- N-(6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl)-5-methylpyridine-2-sulfonamide
- BRD-K19203487-001-01-4
- DA-71170
- DTXCID40105821
- avosentanum
-
- MDL： MFCD23843806
- Inchi： 1S/C23H21N5O5S/c1-15-8-9-19(25-14-15)34(29,30)28-22-20(33-18-7-5-4-6-17(18)31-2)23(32-3)27-21(26-22)16-10-12-24-13-11-16/h4-14H,1-3H3,(H,26,27,28)
- InChI Key： YBWLTKFZAOSWSM-UHFFFAOYSA-N
- SMILES： S(C1C=CC(C)=CN=1)(NC1C(=C(N=C(C2C=CN=CC=2)N=1)OC)OC1C=CC=CC=1OC)(=O)=O
Computed Properties
- Exact Mass: 479.12653
- Monoisotopic Mass: 479.12633996g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 10
- Heavy Atom Count: 34
- Rotatable Bond Count: 8
- Complexity: 732
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 3
- XLogP3: 3.1
- Topological Polar Surface Area: 134?2
Experimental Properties
- Color/Form: NA
- Density: 1.363
- Melting Point: Not available
- Boiling Point: 575.472°C at 760 mmHg
- Flash Point: 301.835 °C
- PSA: 125.42
Avosentan Security Information
- Signal Word：warning
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
-
Warning Statement：
P264Thoroughly clean after treatment
P280Wear protective gloves/Wear protective clothing/Wear protective goggles/Wear a protective mask
P305If it enters the eyes
P351Rinse carefully with water for a few minutes
P338Remove the contact lens(If any)And easy to operate,Continue flushing
P337If eye irritation persists
P313Obtain medical advice/care - Safety Instruction： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Storage Condition：Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month
Avosentan Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | A794710-10mg |
Avosentan |
290815-26-8 | 10mg |
$ 207.00 | 2023-04-19 | ||
| TRC | A794710-100mg |
Avosentan |
290815-26-8 | 100mg |
$ 1642.00 | 2023-04-19 | ||
| Matrix Scientific | 098678-250mg |
N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)-pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide, 95% |
290815-26-8 | 95% | 250mg |
$742.00 | 2023-09-08 | |
| Matrix Scientific | 098678-1g |
N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)-pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide, 95% |
290815-26-8 | 95% | 1g |
$1647.00 | 2023-09-08 | |
| Chemenu | CM167338-50mg |
N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)-pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide |
290815-26-8 | 98% | 50mg |
$427 | 2021-08-05 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci7052-5mg |
Avosentan |
290815-26-8 | 98% | 5mg |
￥895.00 | 2023-09-09 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci7052-10mg |
Avosentan |
290815-26-8 | 98% | 10mg |
￥1611.00 | 2023-09-09 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci7052-50mg |
Avosentan |
290815-26-8 | 98% | 50mg |
￥6271.00 | 2023-09-09 | |
| ChemScence | CS-0625-5mg |
Avosentan |
290815-26-8 | 98.54% | 5mg |
$132.0 | 2022-04-27 | |
| ChemScence | CS-0625-10mg |
Avosentan |
290815-26-8 | 98.54% | 10mg |
$180.0 | 2022-04-27 |
Avosentan Related Literature
-
Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
-
Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
-
Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
Related Categories
- Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyridinylpyrimidines
- Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyridinylpyrimidines
- Pharmaceutical and Biochemical Products Medical Disease Classifications
290815-26-8 (Avosentan) Related Products
- 556066-92-3(Clazosentan Impurity 44)
- 285134-89-6(Clazosentan Impurity 47)
- 180384-43-4(180384-43-4)
- 618879-17-7(2-Pyridinesulfonamide,5-(hydroxymethyl)-N-[6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-)
- 1206674-82-9(Avosentan-d3)
- 180385-03-9(180385-03-9)
- 179400-51-2(Clazosentan Impurity 42)
- 2940974-17-2(Clazosentan Impurity 46)
- 179400-29-4(Clazosentan Impurity 50)
- 285135-04-8(Clazosentan Impurity 51)
Recommended suppliers
ASIACHEM I&E (JIANGSU) CO., LTD
Gold Member
Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
Nantong Boya Environmental Protection Technology Co., Ltd
Gold Member
Audited Supplier
CN Supplier
Bulk
Yunnanjiuzhen
Gold Member
Audited Supplier
CN Supplier
Bulk
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
